Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2A
Clinical trial NCT06314490 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06314490
- Sponsor
- University of California, San Diego
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-16
- Primary completion
- 2026-02-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.